Target intelligence / Profile preview

Neuroligin-4, X-linked (NLGN4X)

Target
NLGN4X
Molecular classification
Cell adhesion molecule, Synaptic cell surface protein, Type-B carboxylesterase/lipase family member, Other
01

Overview

Neuroligin-4, X-linked (NLGN4X), is a neuronal cell-surface adhesion protein that belongs to the neuroligin family and is involved in synapse formation and remodeling in the central nervous system[1][2][5][7]. It acts as a post-synaptic cell adhesion molecule, interacting with presynaptic neurexins to promote synaptic maturation and specificity[1][3][4][5]. NLGN4X is primarily expressed in the human cerebral cortex. Mutations or deletions in NLGN4X are associated with X-linked forms of autism, Asperger syndrome, fragile X syndrome, intellectual disability, and a broader spectrum of neuropsychiatric disorders, including Tourette syndrome and ADHD[1][2][3]. There are currently no known drugs that target NLGN4X directly, and it has no established use as a therapeutic target, though its important roles in brain development and disease make it a strong candidate for future neuropsychiatric research and intervention[3][7].

Other names
Neuroligin 4NLGN4NLGNXNeuroligin 4X
02

Mechanism of action

Not established for any therapeutic drugs; no known targeted mechanism in approved therapies

03

Biological functions

SynaptogenesisCell-cell interactionSynapse formation and remodelingSignal transduction
04

Disease associations

Neurodevelopmental disorderAutism spectrum disorderAsperger syndromeFragile X syndromeTourette syndromeAttention deficit hyperactivity disorder (ADHD)Intellectual disabilityOther neuropsychiatric disorders
05

Safety considerations

None directly related to pharmacologic targeting (no known drugs), but loss-of-function mutations can cause a broad range of neurodevelopmental and neuropsychiatric phenotypes, raising caution for therapeutic strategies
06

Interacting drugs

None known or established as direct pharmacological modulators
07

Biomarkers

Mutations (e.g., deletions within NLGN4X) may be used as genetic biomarkers for autism spectrum disorders and certain neuropsychiatric conditions

Beyond the preview

Go deeper on Neuroligin-4, X-linked (NLGN4X).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuroligin-4, X-linked (NLGN4X).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call